11. CTIM-01. PHASE II TRIAL OF PEMBROLIZUMAB AND LENVATINIB FOR LEPTOMENINGEAL METASTASES. (12th November 2021) Authors: Wang, Nancy; Gerstner, Elizabeth; Cahill, Daniel; Oh, Kevin; Cahill, Jennifer; Brastianos, Priscilla Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. CTIM-02. PHASE II STUDY OF IPILIMUMAB AND NIVOLUMAB IN LEPTOMENINGEAL CARCINOMATOSIS. (12th November 2021) Authors: Strickland, Matthew; Lee, Eudocia Quant; Wang, Nancy; Cohen, Justine; Chukwueke, Ugonma; Forst, Deborah; Eichler, April; Overmoyer, Beth; Lin, Nancy; Chen, Wendy; Bardia, Aditya; Juric, Dejan; Dagogo-Jack, Ibiayi; White, Michael; Dietrich, Jorg; Nayyar, Naema; Kim, Albert; Alvarez-Breckenridge, C... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. CTIM-18. LUMINOS-101: INITIAL SAFETY AND TOLERABILITY OF PVSRIPO AND PEMBROLIZUMAB COMBINATION THERAPY IN RECURRENT GLIOBLASTOMA. (12th November 2021) Authors: Sloan, Andrew; Buerki, Robin; Landi, Daniel; Desjardins, Annick; Friedman, Allan; Ambady, Prakash; Becker, Kevin; Butowski, Nicholas; Cavaliere, Robert; Curry, William; Ong, Shirley; Vega, Rafael; Wen, Patrick; Bockorny, Bruno; Chiocca, E Antonio; Elder, J Bradley; Bulsara, Ketan; Berger, Mitchel... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. CTIM-30. PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS. (12th November 2021) Authors: Brastianos, Priscilla; Kim, Albert; Giobbie-Hurder, Anita; Lee, Eudocia Quant; Wang, Nancy; Eichler, April; Chukwueke, Ugonma; Forst, Deborah; Arrillaga-Romany, Isabel; Dietrich, Jorg; Lou, Kevin; Larson, Juliana; Mora, Joana; Nayyar, Naema; Loeffler, Jay; Oh, Kevin; Shih, Helen; Curry, William; ... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. CTNI-50. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB/OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: UPDATED RESULTS. (14th November 2022) Authors: Hsieh, Annie; Gerstner, Elizabeth; Sahebjam, Solmaz; Piccioni, David; Campian, Jian; Drappatz, Jan; Aiken, Robert; Lee, Eudocia; Welch, Mary; Becker, Kevin; Williams, Mickey; Karlovich, Christopher; Muzikansky, Alona; Giglio, Pierre; Ivy, Percy; Batchelor, Tracy; Arrillaga-Romany, Isabel Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. CTNI-53. RADIATION TREATMENT VOLUMES BEFORE AND AFTER BRAF/MEK THERAPY IN NEWLY DIAGNOSED PAPILLARY CRANIOPHARYNGIOMAS: A CORRELATIVE ANALYSIS OF THE ALLIANCE A071601 PHASE II TRIAL. (12th November 2021) Authors: Shih, Helen; Tabrizi, Shervin; Kabat, Brian; Twohy, Erin; Geyer, Susan; Vora, Shivangi; Gerstner, Elizabeth; Kaufmann, Timothy; Ruff, Michael; Reardon, David; Cohen, Adam; Bota, Daniela; Agarwalla, Pankaj; De la Fuente, Macarena; Lesser, Glen; Campian, Jian; Kumthekar, Priya; Knopp, Michael; Cahi... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. CTNI-54. A SINGLE ARM PHASE II STUDY OF THE DUAL MTORC1/MTORC2 INHIBITOR VISTUSERTIB PROVIDED FOR SPORADIC PATIENTS WITH GRADE II-III MENINGIOMAS THAT RECUR OR PROGRESS AFTER SURGERY AND RADIATION. (12th November 2021) Authors: Plotkin, Scott; Kumthekar, Priya; Wen, Patrick; Barker, Fred; Beauchamp, Roberta; Gerstner, Elizabeth; Muzikansky, Alona; Smith, Miriam; Stemmer-Rachamimov, Anat; Jordan, Justin; Ramesh, Vijaya Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. GENE-63. GENOMIC CHARACTERIZATION OF HUMAN BRAIN METASTASES IDENTIFIES NOVEL DRIVERS OF LUNG ADENOCARCINOMA PROGRESSION. (11th November 2019) Authors: Nayyar, Naema; Shih, David; Bihun, Ivanna; Dagogo-Jack, Ibiayi; Gill, Corey; Aquilanti, Elisa; Bertalan, Mia; Kaplan, Alexander; D'Andrea, Megan; Chukwueke, Ugonma; Ippen, Franziska; Alvarez-Breckenridge, Christopher; Camarda, Nicholas; Lastrapes, Matthew; McCabe, Devin; Kuter, Benjamin; Kaufman,... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Highlights from the Literature. Issue 10 (14th October 2020) Authors: Wright, Karen; Abounader, Roger; Khasraw, Mustafa; Huse, Jason; Gerstner, Elizabeth Editors: Aldape, Kenneth Journal: Neuro-oncology Issue: Volume 22:Issue 10(2020) Page Start: 1419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Highlights from the Literature. Issue 12 (17th December 2019) Authors: Purow, Benjamin; Charest, Alain; Gerstner, Elizabeth; Hegi, Monika; Aldape, Kenneth Journal: Neuro-oncology Issue: Volume 21:Issue 12(2019) Page Start: 1495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗